Post-approval studies (Phase 4)Ended earlyNCT04000555
What this trial is testing
Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI)
Who this might be right for
Clostridium Difficile InfectionClostridium Difficile Infection Recurrence
University of South Florida 26